Latest S-1 registration statements

Dror Ortho-Design, Inc. files an amendment to its Form S-1 registration statement to register the resale of over 2.3 billion shares of common stock by selling securityholders.

M3-Brigade Acquisition V Corp., a blank check company, has filed for a $250 million IPO to pursue a business combination in the North American energy sector.

Tamboran Resources Corporation, focused on natural gas exploration and production in Australia's Beetaloo Basin, is seeking an initial public offering on the New York Stock Exchange.

Tempus AI, a healthcare technology company, has filed for an IPO to further its mission of transforming precision medicine through the application of artificial intelligence.

Onconetix, a commercial-stage biotechnology company, has filed an amendment to its registration statement for the resale of 7,828,812 shares of its common stock by selling stockholders.

Crown Electrokinetics plans to raise up to $36.3 million through the resale of 300 million shares by Keystone Capital Partners, as detailed in a recent S-1 filing.

1606 Corp has filed an S-1 registration statement for the resale of up to 11,503,346 shares of its common stock by the selling stockholder, GHS Investments LLC.

La Rosa Holdings Corp. is registering the resale of up to 8,368,521 shares of common stock by a selling stockholder, Mast Hill Fund, L.P., following private placements in February and April 2024.

EWSB Bancorp, the proposed holding company for East Wisconsin Savings Bank, is offering up to 1,157,188 shares of common stock in connection with a mutual-to-stock conversion to increase capital and enhance its market flexibility.

Centurion Acquisition Corp. files an amendment to its registration statement related to its initial public offering, detailing the terms of units, warrants, and associated agreements.

FibroBiologics is seeking to raise up to $20 million through the sale of units, each comprising one share of common stock and one warrant.

Catheter Precision, Inc. announces a firm commitment public offering of common stock and pre-funded warrants to raise approximately $5 million for operations, clinical trials, and debt repayment.

Kairos Pharma, a clinical-stage biopharmaceutical company, is seeking to raise $6.2 million through an initial public offering to advance its cancer therapeutics pipeline and list its stock on the NYSE American under the symbol KAPA.

Surf Air Mobility has filed a registration statement for the resale of up to 325 million shares of its common stock by a selling stockholder.

Surf Air Mobility has filed a registration statement for the resale of up to 5,807,229 shares of its common stock by a selling stockholder, Palantir Technologies Inc.

Alpha Cognition Inc. files an amendment to its S-1 registration statement, paving the way for a potential public offering and resale of common shares by selling stockholders.

BIOLASE, Inc. announces a best efforts offering of units and pre-funded units to raise capital for working capital and general corporate purposes.

Alzamend Neuro is registering for resale up to 125 million shares of common stock by Orchid Finance LLC, while also addressing ongoing Nasdaq listing compliance issues.

EzFill Holdings plans a firm commitment public offering of common stock, aiming to raise $13.3 million to fund acquisitions, repay debt, and support general corporate purposes, while also closing its acquisition of NextNRG.

Structure Therapeutics is launching a public offering of American Depositary Shares and pre-funded warrants to fuel its clinical programs.

Safe and Green Development Corporation files an S-1 registration statement for the resale of up to 6,266,818 shares of common stock by selling stockholders.

Lexaria Bioscience Corp. has filed a registration statement for the resale of up to 2,917,032 shares of its common stock by a selling stockholder, which are issuable upon the exercise of a warrant issued on April 30, 2024.

iLearningEngines registers for the potential resale of over 100 million shares of common stock and outstanding warrants following its merger with Arrowroot Acquisition Corp.

Rapport Therapeutics files an amendment to its S-1 registration statement, including amended bylaws and details regarding its upcoming IPO and Nasdaq listing.

Getaround, Inc. files an amendment to its S-1 registration statement, covering the potential issuance of common stock and warrants, primarily to satisfy registration rights granted to selling securityholders.

Eureka Acquisition Corp, a Cayman Islands-based blank check company, has filed an amendment to its Form S-1 registration statement for a $50 million IPO, aiming to merge with a target business operating in Asia.

Allurion Technologies has filed an S-1 registration statement for the potential resale of up to 30,191,900 shares of common stock upon conversion of convertible notes held by a selling securityholder.

Melar Acquisition Corp. I, a newly formed blank check company, has filed an S-1 registration statement for a $150 million initial public offering, aiming to pursue a business combination within the emerging finance sector.

AgriFORCE Growing Systems has filed an amendment to its registration statement to allow selling stockholders to resell up to 35,778,875 shares of common stock.

Fidelity seeks SEC approval for its Ethereum Fund, an exchange-traded product designed to track the performance of ether.